Marker Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.14

+0.03 (+2.70%)

As of Aug 15, 2:29 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 89%

Hold 1 11%

Sell 0 0%

Price Target

Analyst Price Target +1,327.2% upside

Low Target $12.16

Average Target $16.27

High Target $21.27

Current Price $1.14

Current
$1.14

Target
$16.27

$12.16 $16.27 avg $21.27

Scenario Analysis

Bear Case

$12.16

966.7%

Low target

Base Case

$16.27

+1,327.2%

Avg target

Bull Case

$21.27

+1,765.8%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$2.46

-53.7% from high

52-Week Low

$0.81

+40.8% from low

Target vs 52W High

$16.27

+561.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+3.3%
AMGN Amgen Inc	Hold	43	49%	$190.87	-54.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-13.3%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.4%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-53.9%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.0%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.4%